Aytu BioPharma Inc (AYTU)
1.54
-0.20
(-11.75%)
USD |
NASDAQ |
Nov 14, 16:00
1.54
0.00 (0.00%)
After-Hours: 19:50
Aytu BioPharma Shareholders Equity (Quarterly): 27.72M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 27.72M |
March 31, 2024 | 30.78M |
December 31, 2023 | 32.85M |
September 30, 2023 | 32.17M |
June 30, 2023 | 39.36M |
March 31, 2023 | 40.91M |
December 31, 2022 | 45.82M |
September 30, 2022 | 53.91M |
June 30, 2022 | 44.31M |
March 31, 2022 | 61.14M |
December 31, 2021 | 105.54M |
September 30, 2021 | 111.50M |
June 30, 2021 | 137.57M |
March 31, 2021 | 143.15M |
December 31, 2020 | 112.69M |
September 30, 2020 | 91.06M |
June 30, 2020 | 95.02M |
March 31, 2020 | 85.70M |
December 31, 2019 | 17.09M |
September 30, 2019 | 2.324M |
June 30, 2019 | 7.088M |
March 31, 2019 | 16.04M |
December 31, 2018 | 19.90M |
September 30, 2018 | 10.13M |
June 30, 2018 | 13.42M |
Date | Value |
---|---|
March 31, 2018 | 12.75M |
December 31, 2017 | 3.031M |
September 30, 2017 | 6.353M |
June 30, 2017 | 4.000M |
March 31, 2017 | 8.521M |
December 31, 2016 | 10.45M |
September 30, 2016 | 7.187M |
June 30, 2016 | 10.09M |
March 31, 2016 | 17.57M |
December 31, 2015 | 15.26M |
September 30, 2015 | 13.41M |
June 30, 2015 | 15.62M |
March 31, 2015 | 0.5513M |
February 28, 2015 | -0.0529M |
November 30, 2014 | -0.0441M |
August 31, 2014 | -0.045M |
May 31, 2014 | -0.036M |
February 28, 2014 | -0.1478M |
November 30, 2013 | -0.1262M |
August 31, 2013 | -0.1109M |
May 31, 2013 | -0.106M |
February 28, 2013 | -0.0948M |
November 30, 2012 | -0.0822M |
August 31, 2012 | -0.0697M |
May 31, 2012 | -0.0549M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
17.09M
Minimum
Dec 2019
143.15M
Maximum
Mar 2021
68.86M
Average
53.91M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
enVVeno Medical Corp | 47.37M |
Bristol-Myers Squibb Co | 17.14B |
Telesis Bio Inc | 9.946M |
CEL-SCI Corp | 8.473M |
AIM ImmunoTech Inc | 6.102M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 118.10M |
Total Liabilities (Quarterly) | 90.38M |
Debt to Equity Ratio | 0.5459 |
Current Ratio | 0.9946 |
Net Debt Paydown Yield | 11.43% |